Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1931 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Two-Time Breast Cancer Warrior Left Devastated After Package Full of Meds... June 25, 2020 Genetic discovery could guide treatment for aggressive childhood cancer June 28, 2021 Color-Blind Groom Sees Color For First Time After Bride Surprises Him... November 9, 2021 Screen-Detected Colorectal Cancers Have a More Favourable Stage Distribution than Colorectal... May 20, 2022 Load more HOT NEWS Study Reinforces Treatment Idea for Cancer with Microsatellite Instability How International Collaboration Has Helped Improve Cancer Care in Nepal PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable... News digest – Genetic links to male breast cancer, bowel cancer...
